Journal of Parkinsons Disease

Papers
(The TQCC of Journal of Parkinsons Disease is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Clinical Trial Highlights: Modulators of Mitochondrial Function132
Introduction: The Earliest Phase of Parkinson’s Disease: Possibilities for Detection and Intervention106
This is NOT the End for Immunotherapy in Parkinson’s Disease – A Perspective from Early Drug Development Scientists80
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease66
Chronotropic Incompetence in Parkinson’s Disease: A Possible Marker of Severe Disease Phenotype?65
A framework to standardize gait study protocols in Parkinson's disease56
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression55
When Parkinson's disease interferes in a couple's life: A qualitative study55
Reply to the Letter to the Editor: Stefani A, “Is it too early to Underrate Genetic onto PD Pathogenesis? Reflections on History”52
Post-Traumatic Stress Disorder and Risk of Parkinson’s Disease in a Veteran Cohort49
Clinical Trial Highlights – Aerobic Exercise for Parkinson’s Disease46
Effects of Very Low- and High-Frequency Subthalamic Stimulation on Motor Cortical Oscillations During Rhythmic Lower-Limb Movements in Parkinson’s Disease Patients46
Jellinger K, “Parkinson’s Disease and Dementia with Lewy Bodies: One and the Same”45
Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson’s Disease44
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease44
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson’s Disease43
Ethical Considerations for Identifying Individuals in the Prodromal/Early Phase of Parkinson’s Disease: A Narrative Review42
Is There an Association Between Parkinson’s Disease and Periodontitis? A Systematic Review and Meta-Analysis40
Rapid Voluntary Blinking as a Clinical Marker of Parkinson’s Disease40
No Higher Risk-Seeking Tendencies or Altered Self-Estimation in a Social Decision-Making Task in Patients with Parkinson’s Disease40
What medicines do people with Parkinson's disease want?39
Are Preformed Fibrils a Model of Parkinson’s Disease?39
A possible pathway to freezing of gait in Parkinson's disease36
Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson’s Disease35
The fixel GI Parkinson's research and integrated support model (PRISM)34
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease33
Early-Onset Parkinson’s Disease: Creating the Right Environment for a Genetic Disorder33
Real-World Evaluation of the Feasibility, Acceptability and Safety of a Remote, Self-Management Parkinson’s Disease Care Pathway: A Healthcare Improvement Initiative33
A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders33
May Bradykinesia Features Aid in Distinguishing Parkinson’s Disease, Essential Tremor, And Healthy Elderly Individuals?31
The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease31
Cerebral Small Vessel Disease Is Associated with Motor, Cognitive, and Emotional Dysfunction in Multiple System Atrophy29
Mild cognitive impairment is not predictive of dementia up to 15 years after subthalamic deep brain stimulation in Parkinson's disease29
Burden of tremor in Parkinson's disease: A survey study29
Burden, Anxiety, and Depression Among Caregivers of Parkinson’s Disease Patients26
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy26
Twenty-five-year experience with apomorphine pump in Parkinson's disease: A real-life long-term retrospective tolerance study26
Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease25
Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson’s Disease on Brain Networks25
Surveying Global Availability of Parkinson’s Disease Treatment25
Feasibility and Proof-of-Concept of Delivering an Autonomous Music-Based Digital Walking Intervention to Persons with Parkinson’s Disease in a Naturalistic Setting24
Modulation of Cerebellar Oscillations with Subthalamic Stimulation in Patients with Parkinson’s Disease24
Nomogram for Early Prediction of Parkinson’s Disease Based on microRNA Profiles and Clinical Variables24
Mortality and causes of death in patients with Parkinson's disease in Taiwan24
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease23
Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice23
Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain22
Deficient Interhemispheric Connectivity Underlies Movement Irregularities in Parkinson’s Disease21
Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia21
The Role of Diet in Parkinson’s Disease21
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease21
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies21
Acknowledgment to Reviewers 202220
Metabolic connectivity of freezing in Parkinson's disease20
Hidden Gems in Neurology: The Syndrome of Hemiparkinsonism-Hemiatrophy20
A glimpse of the end-of-life of people with Parkinson's disease and atypical parkinsonism: A descriptive analysis of electronic health records20
Atypical parkinsonian syndromes in French Guiana: Similarities and differences with Caribbean variants19
Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay19
Gait Declines Differentially in, and Improves Prediction of, People with Parkinson’s Disease Converting to a Freezing of Gait Phenotype19
Motor Memory Consolidation Deficits in Parkinson’s Disease: A Systematic Review with Meta-Analysis19
A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults18
Recruitment for Remote Decentralized Studies in Parkinson’s Disease18
“Tip-of-the-Tongue” Phenomenon in Parkinson’s Disease: A Hidden Gem18
Non-Pharmacological Interventions for People with Parkinson’s Disease: Are We Entering a New Era?18
Do Impulse Control Disorders Impair Car Driving Performance in Patients with Parkinson’s Disease?18
Symmetric and Profound Monoaminergic Degeneration in Parkinson’s Disease with Premotor REM Sleep Behavior Disorder18
Parkinson’s Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson’s Disease18
Effects of Low-Intensity Vestibular Noise Stimulation on Postural Instability in Patients with Parkinson’s Disease18
Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease18
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population18
Self-Reported Visual Complaints in People with Parkinson’s Disease: A Systematic Review18
Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson’s Disease17
Enhancing Trial Delivery in Parkinson’s Disease: Qualitative Insights from PD STAT17
Specialized Allied Health Care for Parkinson’s Disease: State of the Art and Future Directions17
Tackling Parkinson’s Disease as a Global Challenge17
Buspirone regulates cortico-striatal gamma oscillations to ameliorate dyskinesia17
Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review17
Anxiety-related attentional characteristics and their relation to freezing of gait in people with Parkinson's: Cross-validation of the Adapted Gait Specific Attentional Profile (G-SAP)17
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life17
Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?17
Enhancing Participant Engagement in Clinical Studies: Strategies Applied in the Personalized Parkinson Project17
Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis17
Incretin Mimetics Restore the ER-Mitochondrial Axis and Switch Cell Fate Towards Survival in LUHMES Dopaminergic-Like Neurons: Implications for Novel Therapeutic Strategies in Parkinson’s Disease16
Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study16
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model16
The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease16
Enhancing the diagnostic potential of electroretinography in Parkinson's disease: A review of protocol and cohort criteria16
Unveiling the neural network of freezing of gait in Parkinson's disease: A coordinate-based network study16
Utility of a newly created questionnaire on subtle motor symptoms in high-risk subjects with Parkinson's disease16
Feasibility and acceptability of PDConnect, a multi-component intervention to support physical activity in people with Parkinson's disease: A mixed methods study15
Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease15
Evaluating the Psychometric Properties of the Psychological Capital Questionnaire (PCQ) in Patients with Parkinson’s Disease15
Non-Pharmacological Treatment of Autonomic Dysfunction in Parkinson’s Disease and Other Synucleinopathies15
Designing the First Trials for Parkinson’s Prevention15
Kinematic Effects of Combined Subthalamic and Dorsolateral Nigral Deep Brain Stimulation in Parkinson’s Disease15
A Practical Guide to the Evaluation of Compensation Strategies for Gait Impairment in Parkinson’s Disease15
Remote Delivery of Allied Health Therapies in Parkinson’s Disease15
Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery14
Discontinuation or acute unplanned cessation of oral dopaminergic medications in persons with Parkinson's disease: A practice review14
Quantitative Susceptibility Mapping and Free Water Imaging of Substantia Nigra in Parkinson’s Disease14
Diffuse putaminal degeneration without iron deposition in multiple system atrophy14
Neurodegeneration of the Globus Pallidus Internus as a Neural Correlate to Dopa-Response in Freezing of Gait14
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?14
Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity14
Reduced Thickness of the Retina in de novo Parkinson’s Disease Shows A Distinct Pattern, Different from Glaucoma14
Alterations in Self-Aggregating Neuropeptides in Cerebrospinal Fluid of Patients with Parkinsonian Disorders14
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson’s Disease14
40-Year Incidence of Early-Onset Parkinson’s Disease in Southeast Minnesota14
Emerging Role of Environmental Epitranscriptomics and RNA Modifications in Parkinson’s Disease14
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson’s Disease14
Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease14
Natural Health Products for Symptomatic Relief of Parkinson’s Disease: Prevalence, Interest, and Awareness14
Pediatric-onset PRKN disease: New insights into an understudied population13
Biofluid Detection of Pathological α-Synuclein in the Prodromal Phase of Synucleinopathies13
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease13
Prevalence of Concomitant Pathologies in Parkinson’s Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms13
Can People with Parkinson’s Disease Self-Trigger Gait Initiation? A Comparison of Cueing Strategies13
Non-Motor Symptom Management: Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients13
Mycobacterium bovis Infection of a Deep Brain Stimulation System Following Intravesical Bacillus Calmette-Guérin (BCG) Instillation13
Risk of Neurodegeneration in Patients with Rapid Eye Movement Sleep Behavior Disorder13
Inflammasome Activation in Parkinson’s Disease13
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation13
Distinct Patterns of Gene Expression Changes in the Colon and Striatum of Young Mice Overexpressing Alpha-Synuclein Support Parkinson’s Disease as a Multi-System Process13
Spinal Cord Stimulation for Gait Disorders in Parkinson’s Disease13
The Role of Pathogens and Anti-Infective Agents in Parkinson’s Disease, from Etiology to Therapeutic Implications13
Advice to People with Parkinson’s in My Clinic: Orthostatic Hypotension13
Fatigue in de novo Parkinson’s Disease: Expanding the Neuropsychiatric Triad?13
Impaired Inhibitory Control During Walking in Parkinson’s Disease Patients: An EEG Study12
The Use of Image Guided Programming to Improve Deep Brain Stimulation Workflows with Directional Leads in Parkinson’s Disease12
Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study12
Therapeutic Strategies for Immune Transformation in Parkinson’s Disease12
Association Between Body Mass Index Changes and All-Cause Mortality in Parkinson’s Disease12
Axial Impairment Following Deep Brain Stimulation in Parkinson’s Disease: A Surgicogenomic Approach12
New insights from a Malaysian real-world deep brain stimulation cohort12
Immunological Features of LRRK2 Function and Its Role in the Gut-Brain Axis Governing Parkinson’s Disease12
Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson’s Disease with Sleep Disorders12
Obstructive sleep apnea, periodic limb movements, and REM sleep without atonia are common in Parkinson's disease and correlate with motor symptom burden12
Constipation Predicts Cognitive Decline in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group11
Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease11
Letter to the Editor: Is It Too Early to Underrate Genetics onto PD Pathogenesis? Reflections on History11
Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle11
The potential of distributed diagnostics for the early detection of Parkinson's disease11
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer’s Disease to Parkinson’s Disease11
Non-Pharmacological Interventions for Depression and Anxiety in Parkinson’s Disease11
Acknowledgment to Reviewers 202311
Pain Fluctuations in Parkinson’s Disease and Their Association with Motor and Non-Motor Fluctuations11
RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions11
Longitudinal Cohort Study of Verbatim-Reported Postural Instability Symptoms as Outcomes for Online Parkinson’s Disease Trials11
How Information Affects Patients with Parkinson’s Disease: A Scoping Review of the Literature11
Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease11
A PLAN to address the Parkinson pandemic10
PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy10
Worsening of Parkinson’s Disease After Termination of COVID-19 Quarantine Cannot Be Reversed Despite Resumption of Physiotherapy10
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers10
Oscillation-Specific Nodal Differences in Parkinson’s Disease Patients with Anxiety10
Increasing trends in utilization of physical and occupational therapy services in early Parkinson's disease10
Hypomimia May Influence the Facial Emotion Recognition Ability in Patients with Parkinson’s Disease10
Personality Changes After Subthalamic Nucleus Stimulation in Parkinson’s Disease10
Motor outcomes in unilateral, bilateral rapid, and bilateral delayed staging deep brain stimulation for Parkinson’s disease10
Why the Gut Microbiome Must Be Considered When Evaluating the Impact of Pesticides on Parkinson’s Disease Risk10
Disease Progression of Data-Driven Subtypes of Parkinson’s Disease: 5-Year Longitudinal Study from the Early Parkinson’s Disease Longitudinal Singapore (PALS) Cohort10
Integration of Virtual Reality into Transcranial Magnetic Stimulation Improves Cognitive Function in Patients with Parkinson’s Disease with Cognitive Impairment: A Proof-of-Concept Study10
Preparing for Parkinson’s disease prevention trials: Current progress and future directions10
Relating movement behaviours and non-motor characteristics in people with Parkinson's disease: A compositional data analysis approach10
The impact of diet on Parkinson's disease risk: A data-driven analysis in a large Italian case-control population10
Retrograde Procedural Memory in Parkinson’s Disease: A Cross-Sectional, Case-Control Study10
0.17675614356995